{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:36:18Z","timestamp":1788467778430,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.635599\/2021\\u201300"],"award-info":[{"award-number":["88887.635599\/2021\\u201300"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["848\/15"],"award-info":[{"award-number":["848\/15"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2017\/24304\\u20130"],"award-info":[{"award-number":["2017\/24304\\u20130"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.pnpbp.2024.110996","type":"journal-article","created":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T22:37:17Z","timestamp":1710801437000},"page":"110996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Cannabidiol and it fluorinate analog PECS-101 reduces hyperalgesia and allodynia in trigeminal neuralgia via TRPV1 receptors"],"prefix":"10.1016","volume":"132","author":[{"given":"Daniela Maria","family":"Escobar-Espinal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Airam Nicole","family":"Vivanco-Estela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00fabia","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edcio","family":"dos Santos Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Silveira","family":"Guimaraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Del Bel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glauce C.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2024.110996_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109178","article-title":"Modulation of TRPV1 channel function by natural products in the treatment of pain","volume":"330","author":"Abbas","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"22","key":"10.1016\/j.pnpbp.2024.110996_bb0010","article-title":"Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain. Neuropsychopharmacology. Doi: 10.1038\/S41386-019-0585-3 and mechanism of action","volume":"21","author":"Abraham","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0015","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/BF02085029","volume":"37","author":"Agurell","year":"1981","journal-title":"Experientia"},{"key":"10.1016\/j.pnpbp.2024.110996_bb0020","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.toxlet.2020.08.006","article-title":"Carbamazepine induces a bioenergetics disruption to microvascular endothelial cells from the blood-brain barrier","volume":"333","author":"Alelwani","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0025","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2147\/JPR.S258433","article-title":"CBD effects on TRPV1 signaling pathways in cultured DRG neurons","author":"Anand","year":"2020","journal-title":"J. Pain Res."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.998904","article-title":"Reversing painful and non-painful diabetic neuropathy with the capsaicin 8% patch: clinical evidence for pain relief and restoration of function via nerve fiber regeneration","volume":"13","author":"Anand","year":"2022","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.110996_bb0035","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1474-4422(20)30233-7","article-title":"Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia","volume":"19","author":"Bendtsen","year":"2020","journal-title":"The Lancet Neurol."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.110996_bb0040","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jpain.2011.03.005","article-title":"Preservation of acute pain and efferent functions following intrathecal resiniferatoxin-induced analgesia in rats","volume":"12","author":"Bishnoi","year":"2011","journal-title":"J. Pain"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.110996_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158779","article-title":"Fluorinated cannabidiol derivatives: enhancement of activity in mice models predictive of anxiolytic, antidepressant and antipsychotic effects","volume":"11","author":"Breuer","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.pnpbp.2024.110996_bb0050","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.pnpbp.2009.08.017","article-title":"Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids","volume":"33","author":"Campos","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.110996_bb0055","doi-asserted-by":"crossref","unstructured":"Casey, S. L., Atwal, N., Vaughan, C. W. (2017). Cannabis constituent synergy in a mouse neuropathic pain model. Pain 158 (12), 2452\u20132460. doi: https:\/\/doi.org\/10.1097\/J.Pain.0000000000001051.","DOI":"10.1097\/j.pain.0000000000001051"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110996_bb0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbr.2012.06.020","article-title":"Assessment of chronic trigeminal neuropathic pain by the orofacial operant test in rats","volume":"234","author":"Cha","year":"2012","journal-title":"Behav. Brain Res."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.110996_bb0065","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0149-7634(02)00103-3","article-title":"Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive","volume":"26","author":"Chesler","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.110996_bb0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0304-3959(94)00273-H","article-title":"The orofacial formalin test in rats: effects of different formalin concentrations","volume":"62","author":"Clavelou","year":"1995","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.pnpbp.2024.110996_bb0080","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/ptr.2401","article-title":"Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved","volume":"22","author":"Comelli","year":"2008","journal-title":"Phytother. Res."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2024.110996_bb0085","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2006.11.006","article-title":"The non-psychoactive Cannabis constituent Cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain","volume":"556","author":"Costa","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0090","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3389\/fimmu.2018.02009","article-title":"Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age","volume":"9","author":"Crippa","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107808","article-title":"Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson\u2019s disease","volume":"163","author":"Crivelaro do Nascimento","year":"2020","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110996_bb0100","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/j.pain.0000000000001386","article-title":"Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain","volume":"160","author":"De Gregorio","year":"2019","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110996_bb0105","doi-asserted-by":"crossref","first-page":"294","DOI":"10.5530\/jyp.2020.12.80","article-title":"Carbamazepine and its synthesis related impurities profile compilation and its monograph dispute for the best regulatory practice: A review","volume":"12","author":"Debnath","year":"2020","journal-title":"J. Young Pharm."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.110996_bb0110","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.3390\/ijms19113320","article-title":"Antagonism of transient receptor potential ankyrin type-1 channels as a potential target for the treatment of trigeminal neuropathic pain: study in an animal model","volume":"19","author":"Demartini","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.pnpbp.2024.110996_bb0115","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jpain.2017.02.427","article-title":"An improved rodent model of trigeminal neuropathic pain by unilateral chronic constriction injury of distal infraorbital nerve","volume":"18","author":"Ding","year":"2017","journal-title":"J. Pain"},{"key":"10.1016\/j.pnpbp.2024.110996_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.physbeh.2013.11.009","article-title":"Time-dependent analysis of nociception and anxiety-like behavior in rats submitted to persistent inflammation of the temporomandibular joint","volume":"125","author":"do Nascimento","year":"2014","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0125","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.nbd.2016.06.013","article-title":"Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: possible mechanism of action","volume":"94","author":"dos Santos Pereira","year":"2016","journal-title":"Neurobiol. Dis."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.110996_bb0130","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/glia.23472","article-title":"Microglial glutamate release evoked by \u03b1-synuclein aggregates is prevented by dopamine","volume":"66","author":"dos Santos Pereira","year":"2018","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110996_bb0135","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0304-3959(77)90130-0","article-title":"The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats","volume":"4","author":"Dubuisson","year":"1977","journal-title":"Pain"},{"key":"10.1016\/j.pnpbp.2024.110996_bb0140","first-page":"231","article-title":"Carbamazepine induces oxidative stress on rats\u2019 microvascular endothelial cells of the blood-brain barrier","volume":"11","author":"Elmorsy","year":"2020","journal-title":"Ann. Clin. Anal. Med."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120582","article-title":"Pharmacological effects of cannabidiol by transient receptor potential channels","volume":"300","author":"Etemad","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0150","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1007\/s10072-020-04514-2","article-title":"Current application of cannabidiol (CBD) in the management and treatment of neurological disorders","volume":"41","author":"Fiani","year":"2020","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0155","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fphar.2017.00391","article-title":"Cannabidiol is a potential therapeutic for the affective-motivational dimension of incision pain in rats","volume":"8","author":"Genaro","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110996_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10194-023-01589-y","article-title":"Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine","volume":"24","author":"Greco","year":"2023","journal-title":"J. Headache Pain"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110996_bb0165","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00000542-200408000-00030","article-title":"Detection of neuropathic pain in a rat model of peripheral nerve injury","volume":"101","author":"Hogan","year":"2004","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110996_bb0170","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0892-0362(92)90004-T","article-title":"Euthanasia by decapitation: evidence that this technique produces prompt, painless unconsciousness in laboratory rodents","volume":"14","author":"Holson","year":"1992","journal-title":"Neurotoxicol. Teratol."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110996_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041423","article-title":"Targeting peripherally restricted cannabinoid receptor 1, cannabinoid receptor 2, and endocannabinoid-degrading enzymes for the treatment of neuropathic pain including neuropathic orofacial pain","volume":"21","author":"Hossain","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.110996_bb0180","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1021\/cn5000524","article-title":"Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability","volume":"5","author":"Iannotti","year":"2014","journal-title":"ACS Chem. Neurosci."},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2024.110996_bb0185","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0304-3959(98)00172-9","article-title":"Pharmacological studies on a rat model of trigeminal neuropathic pain: baclofen, but not carbamazepine, morphine or tricyclic antidepressants, attenuates the allodynia-like behaviour","volume":"79","author":"Id\u00e4np\u00e4\u00e4n-Heikkil\u00e4","year":"1999","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110996_bb0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40265-020-01429-2","article-title":"TRPV1-targeted drugs in development for human pain conditions","volume":"81","author":"Iftinca","year":"2021","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110996_bb0195","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41598-023-27610-7","article-title":"Modulation of trigeminal neuropathic pain by optogenetic inhibition of posterior hypothalamus in CCI-ION rat","volume":"13","author":"Islam","year":"2023","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.110996_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007021","article-title":"Selective targeting of TRPV1 expressing sensory nerve terminals in the spinal cord for long lasting analgesia","volume":"4","author":"Jeffry","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110996_bb0205","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pnpbp.2012.03.002","article-title":"A novel trigeminal neuropathic pain model: compression of the trigeminal nerve root produces prolonged nociception in rats","volume":"38","author":"Jeon","year":"2012","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.110996_bb0210","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.brainres.2019.03.014","article-title":"Cannabidiol attenuates mechanical allodynia in streptozotocin-induced diabetic rats via serotonergic system activation through 5-HT1A receptors","volume":"1715","author":"Jesus","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.114076","article-title":"Cannabidiol enhances the antinociceptive effects of morphine and attenuates opioid-induced tolerance in the chronic constriction injury model","volume":"435","author":"Jesus","year":"2022","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117379","article-title":"Design, synthesis, and analgesia evaluation of novel transient receptor potential Vanilloid 1 (TRPV1) agonists modified from Cannabidiol (CBD)","volume":"90","author":"Jin","year":"2023","journal-title":"Bioorg. Med. Chem."},{"issue":"20","key":"10.1016\/j.pnpbp.2024.110996_bb0225","doi-asserted-by":"crossref","first-page":"11177","DOI":"10.3390\/ijms222011177","article-title":"Inhibition of spinal TRPV1 reduces NMDA receptor 2B phosphorylation and produces anti-nociceptive effects in mice with inflammatory pain","volume":"22","author":"Kang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110996_bb0230","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.neuron.2013.12.011","article-title":"Central terminal sensitization of TRPV1 by descending serotonergic facilitation modulates chronic pain","volume":"81","author":"Kim","year":"2014","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110996_bb0235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41573-021-00268-4","article-title":"Advances in TRP channel drug discovery: from target validation to clinical studies","volume":"21","author":"Koivisto","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.110996_bb0240","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jneumeth.2008.10.033","article-title":"Von Frey\u2019s hairs--a review of their technology and use--a novel automated von Frey device for improved testing for hyperalgesia","volume":"177","author":"Lambert","year":"2009","journal-title":"J. Neurosci. Methods"},{"issue":"16","key":"10.1016\/j.pnpbp.2024.110996_bb0245","doi-asserted-by":"crossref","first-page":"8811","DOI":"10.3390\/ijms22168811","article-title":"Ji017 attenuates oxaliplatin-induced cold allodynia via spinal trpv1 and astrocytes inhibition in mice","volume":"22","author":"Lee","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110996_bb0250","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neuropharm.2007.04.019","article-title":"The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain","volume":"53","author":"Liang","year":"2007","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.pnpbp.2024.110996_bb0255","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.joen.2021.06.007","article-title":"Activation of transient receptor potential ankyrin 1 and vanilloid 1 channels promotes odontogenic differentiation of human dental pulp cells","volume":"47","author":"Lou","year":"2021","journal-title":"J. Endod."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.110996_bb0260","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1177\/0333102416687280","article-title":"Trigeminal neuralgia\u2013diagnosis and treatment","volume":"37","author":"Maarbjerg","year":"2017","journal-title":"Cephalalgia"},{"key":"10.1016\/j.pnpbp.2024.110996_bb0265","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fphar.2016.00257","article-title":"Dual-acting compounds targeting endocannabinoid and endovanilloid systems\u2014a novel treatment option for chronic pain management","volume":"7","author":"Malek","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0270","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.biocel.2014.08.007","article-title":"Neuropathic orofacial pain: cannabinoids as a therapeutic avenue","volume":"55","author":"McDonough","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"33","key":"10.1016\/j.pnpbp.2024.110996_bb0275","doi-asserted-by":"crossref","first-page":"13525","DOI":"10.1073\/pnas.0705924104","article-title":"TRPA1 mediates formalin-induced pain","volume":"104","author":"McNamara","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.pnpbp.2024.110996_bb0280","series-title":"Cannabidiol for Pain Treatment: Focus on Pharmacology","author":"Mlost","year":"2020"},{"key":"10.1016\/j.pnpbp.2024.110996_bb0285","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fnmol.2018.00487","article-title":"Cannabinoid Ligands Targeting TRP Channels","volume":"11","author":"Muller","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.pnpbp.2024.110996_bb0290","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bbr.2016.08.012","article-title":"Activation of the trigeminal \u03b12-adrenoceptor produces sex-specific, estrogen dependent thermal antinociception and antihyperalgesia using an operant pain assay in the rat","volume":"314","author":"Nag","year":"2016","journal-title":"Behav. Brain Res."},{"issue":"10","key":"10.1016\/j.pnpbp.2024.110996_bb0295","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.mpaic.2019.07.009","article-title":"Pharmacology in the management of chronic pain","volume":"20","author":"Nisbet","year":"2019","journal-title":"Anaesthesia & Intensive Care Med."},{"issue":"Suppl. 2","key":"10.1016\/j.pnpbp.2024.110996_bb0300","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.21037\/apm.2017.08.04","article-title":"Modulating the endocannabinoid pathway as treatment for peripheral neuropathic pain: a selected review of preclinical studies","volume":"6","author":"O\u2019Hearn","year":"2017","journal-title":"Ann. Palliat. Med."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136167","article-title":"Anticonvulsant and neuroprotective effects of carbamazepine-levetiracetam adjunctive treatment in convulsive status epilepticus rat model: inhibition of cholinergic transmission","volume":"762","author":"Osuntokun","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.110996_bb0310","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/bcpt.13710","article-title":"A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)","volume":"130","author":"Peng","year":"2022","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"43","key":"10.1016\/j.pnpbp.2024.110996_bb0315","doi-asserted-by":"crossref","first-page":"8991","DOI":"10.1523\/JNEUROSCI.0547-21.2021","article-title":"Mechanisms underlying the selective therapeutic efficacy of carbamazepine for attenuation of trigeminal nerve injury pain","volume":"41","author":"Pineda-Farias","year":"2021","journal-title":"J. Neurosci."},{"issue":"8\u20139","key":"10.1016\/j.pnpbp.2024.110996_bb0320","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.lfs.2012.08.010","article-title":"TRP channels and analgesia","volume":"92","author":"Premkumar","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114237","article-title":"Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies","volume":"359","author":"Reddy","year":"2023","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneumeth.2015.03.022","article-title":"A novel operant-based behavioral assay of mechanical allodynia in the orofacial region of rats","volume":"248","author":"Rohrs","year":"2015","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.pnpbp.2024.110996_bb0335","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neuroscience.2012.08.015","article-title":"Characterization of bilateral trigeminal constriction injury using an operant facial pain assay","volume":"224","author":"Rossi","year":"2012","journal-title":"Neuroscience"},{"issue":"23","key":"10.1016\/j.pnpbp.2024.110996_bb0340","doi-asserted-by":"crossref","first-page":"19462","DOI":"10.1074\/jbc.M111.289751","article-title":"Agonist- and Ca2+\u2212dependent desensitization of TRPV1 channel targets the receptor to lysosomes for degradation","volume":"287","author":"Sanz-Salvador","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0345","series-title":"A Brief Review on Carbamazepine: History, Pharmacological Properties and Environmental Impact","author":"Schwarz","year":"2021"},{"key":"10.1016\/j.pnpbp.2024.110996_bb0350","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.pnpbp.2017.07.012","article-title":"Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative","volume":"79","author":"Silva","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110996_bb0355","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s13311-021-01164-w","article-title":"The cannabidiol analog PECS-101 prevents chemotherapy-induced neuropathic pain via PPAR\u03b3 receptors","volume":"19","author":"Silva","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pnpbp.2024.110996_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108712","article-title":"Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: possible role of CB1 and TRPV1 receptors","volume":"197","author":"Silva-Cardoso","year":"2021","journal-title":"Neuropharmacology"},{"issue":"21","key":"10.1016\/j.pnpbp.2024.110996_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25215186","article-title":"Molecular targets of Cannabidiol in experimental models of neurological disease","volume":"25","author":"Silvestro","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.pnpbp.2024.110996_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174625","article-title":"Modulation of excitatory synaptic transmissions by TRPV1 in the spinal trigeminal subnucleus caudalis neurons of neuropathic pain rats","volume":"913","author":"Tamada","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110996_bb0375","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: an evaluation of the method","volume":"51","author":"Tj\u00f8lsen","year":"1992","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.pnpbp.2024.110996_bb0380","doi-asserted-by":"crossref","first-page":"690","DOI":"10.7150\/ijms.4706","article-title":"Aberrant TRPV1 expression in heat hyperalgesia associated with trigeminal neuropathic pain","volume":"9","author":"Urano","year":"2012","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110996_bb0385","article-title":"Decapitation in rats: latency to unconsciousness and the \u2018wave of death\u2019","volume":"6","author":"van Rijn","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2024.110996_bb0390","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.neulet.2018.11.057","article-title":"Orofacial operant behaviors and electrophysiological properties of trigeminal ganglion neurons following masseter muscle inflammation in rats","volume":"694","author":"Viatchenko-Karpinski","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2024.110996_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108700","article-title":"Cannabidiol has therapeutic potential for myofascial pain in female and male parkinsonian rats","volume":"196","author":"Vivanco-Estela","year":"2021","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110996_bb0400","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.brainresrev.2008.12.006","article-title":"Therapeutic potential ofvanilloid receptor TRPV1 agonists and antagonists as analgesics:Recent advances and setbacks","volume":"60","author":"Wong","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.110996_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40064-016-2071-2","article-title":"Central antinociceptive activity of peripherally applied botulinum toxin type A in lab rat model of trigeminal neuralgia","volume":"5","author":"Wu","year":"2016","journal-title":"Springerplus"},{"key":"10.1016\/j.pnpbp.2024.110996_bb0410","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"key":"10.1016\/j.pnpbp.2024.110996_bb0415","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fphar.2017.00259","article-title":"Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life","volume":"8","author":"Zuardi","year":"2017","journal-title":"Front. Pharmacol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624000642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624000642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T10:42:04Z","timestamp":1777545724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624000642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":82,"alternative-id":["S0278584624000642"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.110996","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol and it fluorinate analog PECS-101 reduces hyperalgesia and allodynia in trigeminal neuralgia via TRPV1 receptors","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.110996","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110996"}}